Steminent Biotherapeutics, Inc.

Steminent Biotherapeutics, Inc.

TTPEX:7729
180.00
TWD
+0.50
(+0.28%)
6.28BMarket Cap

Latest Stock Split

Apr 29, 2026

998:983

For every 983 shares held, investors received 998. The price per share adjusted from $82.70 to $81.46.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Apr 29, 2026
    Before$82.70
    Split ratio998:983
    After$81.46
    Forward
  2. Aug 28, 2025
    Before$42.85
    Split ratio343:320
    After$39.98
    Forward

About Steminent Biotherapeutics, Inc. stock splits

Steminent Biotherapeutics, Inc. (TPEX:7729) operates in the Biotechnology industry.

Steminent Biotherapeutics, Inc. company overview

When did Steminent Biotherapeutics, Inc. stock split?

Steminent Biotherapeutics, Inc.'s most recent stock split was on April 29, 2026. It was a 998-for-983 forward split, so shareholders received 998 shares for every 983 they held.

What is Steminent Biotherapeutics, Inc.'s stock split history?

Steminent Biotherapeutics, Inc. (TPEX:7729) has split its stock 2 times: a 343-for-320 split on August 28, 2025 and a 998-for-983 split on April 29, 2026.

How many times has Steminent Biotherapeutics, Inc. stock split?

Steminent Biotherapeutics, Inc. has split its stock 2 times. This history records 2 forward splits between August 28, 2025 and April 29, 2026.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Steminent Biotherapeutics, Inc.'s 998-for-983 split on April 29, 2026, every 983 shares became 998 shares.

Will Steminent Biotherapeutics, Inc. split its stock again?

Steminent Biotherapeutics, Inc. has not announced a new split in our records. Its most recent split was on April 29, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:7729 split will appear on this page.